Entity Common Stock, Shares Outstanding of Eiger BioPharmaceuticals, Inc. from Q1 2014 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q1 2014 to Q1 2024.
  • Eiger BioPharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Apr 2024 was 1.48M shares, a 96.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.48M -42.7M -96.6% 04 Apr 2024 10-K 08 Apr 2024
Q3 2023 44.4M +310K +0.7% 06 Nov 2023 10-Q 09 Nov 2023
Q2 2023 44.3M +330K +0.75% 09 Aug 2023 10-Q 14 Aug 2023
Q1 2023 44.2M +9.52M +27.5% 13 Mar 2023 10-K 17 Mar 2023
Q3 2022 44.1M +10.1M +29.7% 01 Nov 2022 10-Q 03 Nov 2022
Q2 2022 44M +10M +29.5% 01 Aug 2022 10-Q 04 Aug 2022
Q1 2022 34.6M +738K +2.18% 07 Mar 2022 10-K 10 Mar 2022
Q3 2021 34M +1.44M +4.44% 01 Nov 2021 10-Q 04 Nov 2021
Q2 2021 34M +4.71M +16.1% 02 Aug 2021 10-Q 05 Aug 2021
Q1 2021 33.9M +9.34M +38% 05 Mar 2021 10-K 09 Mar 2021
Q3 2020 32.5M +8.04M +32.8% 02 Nov 2020 10-Q 05 Nov 2020
Q2 2020 29.2M +4.8M +19.6% 03 Aug 2020 10-Q 06 Aug 2020
Q1 2020 24.6M +5.3M +27.5% 05 Mar 2020 10-K 13 Mar 2020
Q3 2019 24.5M +5.4M +28.3% 04 Nov 2019 10-Q 07 Nov 2019
Q2 2019 24.4M +10.2M +71.6% 05 Aug 2019 10-Q 08 Aug 2019
Q1 2019 19.3M +8.73M +83% 11 Mar 2019 10-K 14 Mar 2019
Q3 2018 19.1M +8.58M +81.6% 05 Nov 2018 10-Q 09 Nov 2018
Q2 2018 14.2M +5.88M +70.2% 06 Aug 2018 10-Q 10 Aug 2018
Q1 2018 10.5M +2.17M +25.9% 02 Mar 2018 10-K 09 Mar 2018
Q3 2017 10.5M +2.16M +25.8% 03 Nov 2017 10-Q 09 Nov 2017
Q2 2017 8.37M +1.26M +17.8% 03 Aug 2017 10-Q 11 Aug 2017
Q1 2017 8.36M +1.42M +20.4% 16 Mar 2017 10-K 23 Mar 2017
Q3 2016 8.36M -15.6M -65.1% 03 Nov 2016 10-Q 08 Nov 2016
Q2 2016 7.1M -16.8M -70.3% 04 Aug 2016 10-Q 10 Aug 2016
Q1 2016 6.95M -16.9M -70.9% 31 Mar 2016 10-Q 16 May 2016
Q3 2015 23.9M +611K +2.62% 31 Oct 2015 10-Q 09 Nov 2015
Q2 2015 23.9M +5.38M +29% 31 Jul 2015 10-Q 11 Aug 2015
Q1 2015 23.8M +5.33M +28.8% 13 Mar 2015 10-K 31 Mar 2015
Q3 2014 23.3M 31 Oct 2014 10-Q 12 Nov 2014
Q2 2014 18.5M 28 Jul 2014 10-Q 07 Aug 2014
Q1 2014 18.5M 25 Apr 2014 10-Q 13 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.